01 1Alphora Research
01 1ERIBULIN MESYLATE
01 1Canada
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-05-14
Pay. Date : 2019-03-27
DMF Number : 33425
Submission : 2019-03-14
Status : Active
Type : II
20
Eurofins Cdmo Alphora Inc, based in Canada, is a pharmaceutical company.
They are recognized for Streamline Drug Development - bring your Drug to Clinic Faster.
One of their notable products is ERIBULIN MESYLATE, with a corresponding US DMF Number 33425.
Remarkably, this DMF maintains an Active status since its submission on March 14, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 14, 2019, and payment made on March 27, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
